Delphi says Joseph Massaro has been appointed chief financial officer and senior vice president, succeeding Mark Murphy, who has elected to leave the company to pursue other opportunities.

“Delphi is in a unique position to capitalise on the strength and experience of our highly capable finance team to support our continued strong performance and commitment to our customers and shareholders,” said Delphi president and CEO, Kevin Clark.

“Joe has been a significant contributor to Delphi’s success over the past three years and will continue to have a positive impact on Delphi in the future.

“His proven finance track record in multiple companies, across multiple industries, coupled with his understanding of Delphi’s operations, make Joe an exceptional choice for the chief financial officer role.

“We thank Mark for his service to Delphi and wish him every success in his new endeavours.”

Massaro joined Delphi in 2013 as vice president, Internal Audit, and was appointed to the position of vice president, corporate controller in 2014.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Before joining Delphi, Massaro was a managing director at Liberty Lane Partners from 2008-2013, a private-equity investment firm focused on building and improving middle-market companies.

While there he also served as chief financial officer of inVentiv Health, which is a provider of pharmaceutical development services and a Liberty Lane portfolio company, from 2010 to 2013.